- Home
- CSBR vs TGE Comparison
CSBR vs TGE Comparison
Compare CSBR & TGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CSBR | TGE |
|---|---|---|
| Founded | 1985 | 2023 |
| Country | United States | France |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Newspapers/Magazines |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 82.7M | 68.3M |
| IPO Year | 2015 | N/A |
Fundamental Metrics
Financial Performance| Metric | CSBR | TGE |
|---|---|---|
| Price | $6.34 | $1.32 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 5.7K | ★ 45.7K |
| Earning Date | 06-22-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 161.11 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,900,000.00 | N/A |
| Revenue This Year | $4.84 | N/A |
| Revenue Next Year | $11.51 | N/A |
| P/E Ratio | ★ N/A | $2.99 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $5.50 | $0.78 |
| 52 Week High | $10.25 | $12.99 |
Technical Indicators
Market Signals| Indicator | CSBR | TGE |
|---|---|---|
| Relative Strength Index (RSI) | 50.42 | 45.27 |
| Support Level | $6.11 | $1.26 |
| Resistance Level | $6.24 | $1.62 |
| Average True Range (ATR) | 0.21 | 0.11 |
| MACD | 0.06 | -0.01 |
| Stochastic Oscillator | 78.75 | 15.06 |
Price Performance
Historical ComparisonAbout CSBR Champions Oncology Inc.
Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services.
About TGE The Generation Essentials Group Class A Ordinary Shares
The Generation Essentials Group is a media and entertainment company. Its publications L'Officiel and The Art Newspaper publish print editions in a total of nearly 28 countries and territories and digital contents. It operate in the movie production sector having produced various Asia-focused movies. It operate in three operating segments: media and entertainment segment, hotel operations, hospitality and VIP services segment and strategic investment segment. Key revenue is generated from strategic investment segment that is engage in proprietary investments and management of portfolio, including listed and unlisted equity shares investments and movie income right investments.